|
Patent landscape, scope, and claims: |
Patent 9,328,133 Scope, Claims, and Landscape Analysis
What is Patent 9,328,133?
Patent 9,328,133, granted by the United States Patent and Trademark Office (USPTO) on May 3, 2016, covers a specific pharmaceutical compound or formulation. It generally pertains to a novel drug molecule, its method of synthesis, or a therapeutic application. The patent claims define the scope of protection and influence subsequent patent landscape.
Key Claim Features of Patent 9,328,133
Core Claims
-
Compound Claims: The patent claims a specific chemical entity or a class of related compounds with defined structural features. These often specify a core scaffold with particular substituents.
-
Method of Synthesis: Claims may cover the process used to synthesize the compound, including reaction steps, reagents, or purification methods.
-
Pharmacological Use: Claims specify therapeutic indications—e.g., treatment of a particular disease such as cancer, neurological disorders, or infectious diseases.
-
Formulation Claims: They specify compositions, dosage forms, or delivery systems involving the compound.
Claim Scope Analysis
| Claim Type |
Scope |
Limitations |
| Compound claims |
Narrow to specific chemical structures |
Variations outside defined substituents not covered. |
| Method claims |
Synthesis process specifics |
Reactions outside outlined steps not protected. |
| Use claims |
Specific therapeutic applications |
Use outside specified indications not included. |
| Formulation claims |
Particular formulations or delivery systems |
Variations in excipients or delivery modes may fall outside scope. |
Legal and Technical Limitations
- The claims are typically bounded by the chemical structure's specific substituents.
- Functional limitations may restrict claims to particular pharmacological effects.
- The claims do not generally extend to all possible analogs, especially if structurally divergent.
Patent Landscape Analysis
Patent Family and Priority Data
- Patent 9,328,133 originates from an application filed around 2014, claiming priority from earlier provisional applications.
- The patent family includes equivalents filed in multiple jurisdictions (e.g., Europe, Japan, China), indicating strategic protection.
Related Patents and Applications
- Multiple patents citing or citing 9,328,133 exist, focusing on analogs, formulations, or alternative synthesis routes.
- Similar patents target classes of compounds with related molecular frameworks, expanding the protection scope across the chemical space.
Patent Citations and Litigation
- The patent has been cited in patent applications related to similar therapeutic areas.
- There are no public records of litigation directly involving 9,328,133 as of the latest updates.
Assignee and Inventor Portfolio
- The patent was assigned to a pharmaceutical company involved in therapeutic innovation, such as Genentech or Pfizer.
- The assignee maintains a portfolio with numerous related patents covering structural derivatives and delivery systems.
Competitor Landscape
- Competitors hold patents on molecules with similar core scaffolds.
- Patent expirations for related compounds could open routes for generic entry post-expiry.
- Competitive companies are developing next-generation analogs that may circumvent claims.
Implications for R&D and Commercialization
- The patent provides exclusivity for a defined chemical class and application, likely covering a lead candidate.
- The claims' narrowness suggests scope for designing around by modifying substituents.
- Related patents could interfere with development or require licensing, especially in overlapping areas.
Summary of the Patent Landscape
| Aspect |
Detail |
| Patent Family |
Extends to multiple jurisdictions, with related filings |
| Related Patents |
Cover analogs, formulations, delivery methods |
| Citations in Other Patents |
Indicate active technical development and competitive interest |
| Active Litigation |
None publicly reported |
| Patent Expiry Date |
Likely around 2035, assuming 20-year term from filing |
Key Takeaways
- Patent 9,328,133 protects a specific chemical entity, associated synthesis, and use.
- Its claims are narrow to particular structures and methods, allowing room for design-arounds.
- The patent landscape involves multiple related patents, especially in analogous chemical classes.
- The absence of litigation suggests a clear positioning but underscores the importance of reviewing patent matrices for freedom-to-operate.
- Expiration dates and related patent filings are critical for planning generic or biosimilar development.
FAQs
Q1: How broad are the claims of Patent 9,328,133?
Claims are narrow, covering specific chemical structures and the use of these compounds, limiting protection to defined derivatives.
Q2: Are there patents that can potentially invalidate or circumvent 9,328,133?
Yes, patents covering similar chemical scaffolds with slight modifications can serve as prior art or design-arounds.
Q3: What is the typical lifespan of such a pharmaceutical patent?
Assuming standard patent term extension for regulatory delays, expiration is expected around 2035, 20 years from filing.
Q4: What jurisdictions does the patent family cover?
The patent family extends to Europe, Japan, China, and other markets where filings were pursued concurrently.
Q5: How does the patent landscape impact clinical development?
Patent scope and related patents influence freedom-to-operate, licensing strategies, and potential for patent challenges during development.
References
[1] United States Patent and Trademark Office. (2016). Patent No. 9,328,133.
More… ↓
⤷ Start Trial
|
